CNS 0 3 0 3 B-cancer
tumors 4 10 4 10 I-cancer
: 10 11 10 11 O
High 12 16 12 16 O
risk 17 21 17 21 O
malignant 22 31 22 31 B-cancer
brain 32 37 32 37 I-cancer
tumors 38 44 38 44 I-cancer
that 45 49 45 49 O
are 50 53 50 53 O
recurrent 54 63 54 63 O
or 64 66 64 66 O
refractory 67 77 67 77 O
to 78 80 78 80 O
standard 81 89 81 89 B-treatment
frontline 90 99 90 99 I-treatment
therapy 100 107 100 107 I-treatment
are 108 111 108 111 O
eligible 112 120 112 120 O

Cardiac 0 7 121 128 O
: 7 8 128 129 O
For 9 12 130 133 O
patients 13 21 134 142 O
not 22 25 143 146 O
taking 26 32 147 153 O
inotropic 33 42 154 163 B-treatment
medications 43 54 164 175 I-treatment
and 55 58 176 179 O
who 59 62 180 183 O
do 63 65 184 186 O
not 66 69 187 190 O
have 70 74 191 195 O
cardiac 75 82 196 203 B-chronic_disease
failure 83 90 204 211 I-chronic_disease
requiring 91 100 212 221 O
therapy 101 108 222 229 B-treatment

Children 0 8 230 238 O
greater 9 16 239 246 O
than 17 21 247 251 O
or 22 24 252 254 O
equal 25 30 255 260 O
to 31 33 261 263 O
12 34 36 264 266 B-lower_bound
years 37 42 267 272 I-lower_bound
of 43 45 273 275 O
age 46 49 276 279 B-age
who 50 53 280 283 O
have 54 58 284 288 O
not 59 62 289 292 O
provided 63 71 293 301 O
informed 72 80 302 310 O
assent 81 87 311 317 O
in 88 90 318 320 O
the 91 94 321 324 O
presence 95 103 325 333 O
of 104 106 334 336 O
a 107 108 337 338 O
parent 109 115 339 345 O
and 116 119 346 349 O
an 120 122 350 352 O
Attending 123 132 353 362 O
physician 133 142 363 372 O
who 143 146 373 376 O
is 147 149 377 379 O
not 150 153 380 383 O
a 154 155 384 385 O
member 156 162 386 392 O
of 163 165 393 395 O
the 166 169 396 399 O
recipient 170 179 400 409 O
's 179 181 409 411 O
care 182 186 412 416 O
team 187 191 417 421 O

Children 0 8 422 430 O
greater 9 16 431 438 O
than 17 21 439 443 O
or 22 24 444 446 O
equal 25 30 447 452 O
to 31 33 453 455 O
12 34 36 456 458 B-lower_bound
- 36 37 458 459 O
17.9 37 41 459 463 B-upper_bound
years 42 47 464 469 O
of 48 50 470 472 O
age 51 54 473 476 B-age
who 55 58 477 480 O
have 59 63 481 485 O
inadequate 64 74 486 496 O
peripheral 75 85 497 507 O
vein 86 90 508 512 O
access 91 97 513 519 O
to 98 100 520 522 O
safely 101 107 523 529 O
undergo 108 115 530 537 O
apheresis 116 125 538 547 B-treatment

Children 0 8 548 556 O
less 9 13 557 561 O
than 14 18 562 566 O
12 19 21 567 569 B-upper_bound
years 22 27 570 575 I-upper_bound
of 28 30 576 578 O
age 31 34 579 582 B-age
( 35 36 583 584 O
marrow 36 42 584 590 O
) 42 43 590 591 O
or 44 46 592 594 O
less 47 51 595 599 O
than 52 56 600 604 O
18 57 59 605 607 B-upper_bound
years 60 65 608 613 I-upper_bound
of 66 68 614 616 O
age 69 72 617 620 O
( 73 74 621 622 O
PBSC 74 78 622 626 B-treatment
) 78 79 626 627 O

Diffuse 0 7 628 635 B-cancer
intrinsic 8 17 636 645 I-cancer
pontine 18 25 646 653 I-cancer
gliomas 26 33 654 661 I-cancer
( 34 35 662 663 I-cancer
DIPG 35 39 663 667 I-cancer
) 39 40 667 668 I-cancer
are 41 44 669 672 O
excluded 45 53 673 681 O

Donors 0 6 682 688 O
unable 7 13 689 695 O
or 14 16 696 698 O
unwilling 17 26 699 708 O
to 27 29 709 711 O
undergo 30 37 712 719 O
marrow 38 44 720 726 O
harvest 45 52 727 734 O
or 53 55 735 737 O
PBSC 56 60 738 742 O
collection 61 71 743 753 O
for 72 75 754 757 O
the 76 79 758 761 O
initial 80 87 762 769 O
HCT 88 91 770 773 B-treatment
, 91 92 773 774 O
storage 93 100 775 782 O
of 101 103 783 785 O
autologous 104 114 786 796 O
blood 115 120 797 802 O
prior 121 126 803 808 O
to 127 129 809 811 O
marrow 130 136 812 818 O
harvest 137 144 819 826 O
( 145 146 827 828 O
if 146 148 828 830 O
applicable 149 159 831 841 O
) 159 160 841 842 O
, 160 161 842 843 O
or 162 164 844 846 O
apheresis 165 174 847 856 O
one 175 178 857 860 B-lower_bound
week 179 183 861 865 I-lower_bound
after 184 189 866 871 I-lower_bound
marrow 190 196 872 878 O
harvest 197 204 879 886 O

Donors 0 6 887 893 O
who 7 10 894 897 O
are 11 14 898 901 O
not 15 18 902 905 O
expected 19 27 906 914 O
to 28 30 915 917 O
meet 31 35 918 922 O
the 36 39 923 926 O
minimum 40 47 927 934 O
target 48 54 935 941 O
dose 55 59 942 946 O
of 60 62 947 949 O
marrow 63 69 950 956 O
cells 70 75 957 962 O
( 76 77 963 964 O
1 77 78 964 965 B-lower_bound
x 79 80 966 967 I-lower_bound
108 81 84 968 971 I-lower_bound
total 85 90 972 977 I-lower_bound
nucleated 91 100 978 987 I-lower_bound
cells 101 106 988 993 I-lower_bound
/ 106 107 993 994 I-lower_bound
kg 107 109 994 996 I-lower_bound
recipient 110 119 997 1006 O
weight 120 126 1007 1013 B-clinical_variable
) 126 127 1013 1014 O
for 128 131 1015 1018 O
the 132 135 1019 1022 O
initial 136 143 1023 1030 B-treatment
marrow 144 150 1031 1037 I-treatment
HCT 151 154 1038 1041 I-treatment
or 155 157 1042 1044 O
PBSC 158 162 1045 1049 B-treatment
transplant 163 173 1050 1060 I-treatment
( 174 175 1061 1062 O
5.0 175 178 1062 1065 B-lower_bound
x 179 180 1066 1067 I-lower_bound
106 181 184 1068 1071 I-lower_bound
CD34 185 189 1072 1076 I-lower_bound
/ 189 190 1076 1077 I-lower_bound
kg 190 192 1077 1079 I-lower_bound
recipient 193 202 1080 1089 O
weight 203 209 1090 1096 O
) 209 210 1096 1097 O

Ewing 0 5 1098 1103 B-cancer
Sarcoma 6 13 1104 1111 I-cancer
Family 14 20 1112 1118 I-cancer
of 21 23 1119 1121 I-cancer
Tumors 24 30 1122 1128 I-cancer
( 31 32 1129 1130 I-cancer
EWS 32 35 1130 1133 I-cancer
) 35 36 1133 1134 I-cancer
[ 37 38 1135 1136 O
includes 38 46 1136 1144 O
both 47 51 1145 1149 O
bone 52 56 1150 1154 O
and 57 60 1155 1158 O
soft 61 65 1159 1163 O
tissue 66 72 1164 1170 O
Ewing 73 78 1171 1176 O
and 79 82 1177 1180 O
Peripheral 83 93 1181 1191 O
Primitive 94 103 1192 1201 B-cancer
Neuroectodermal 104 119 1202 1217 I-cancer
Tumors 120 126 1218 1224 I-cancer
( 127 128 1225 1226 I-cancer
PNET 128 132 1226 1230 I-cancer
) 132 133 1230 1231 I-cancer
] 133 134 1231 1232 O

Fertile 0 7 1233 1240 O
females 8 15 1241 1248 B-gender
who 16 19 1249 1252 O
are 20 23 1253 1256 O
unwilling 24 33 1257 1266 B-contraception_consent
to 34 36 1267 1269 I-contraception_consent
use 37 40 1270 1273 I-contraception_consent
contraceptive 41 54 1274 1287 I-contraception_consent
techniques 55 65 1288 1298 I-contraception_consent
during 66 72 1299 1305 O
and 73 76 1306 1309 O
for 77 80 1310 1313 O
the 81 84 1314 1317 O
twelve 85 91 1318 1324 B-upper_bound
months 92 98 1325 1331 I-upper_bound
following 99 108 1332 1341 O
treatment 109 118 1342 1351 B-treatment
, 118 119 1351 1352 O
as 120 122 1353 1355 O
well 123 127 1356 1360 O
as 128 130 1361 1363 O
females 131 138 1364 1371 O
who 139 142 1372 1375 O
are 143 146 1376 1379 B-pregnancy
pregnant 147 155 1380 1388 I-pregnancy
or 156 158 1389 1391 O
actively 159 167 1392 1400 O
breast 168 174 1401 1407 O
feeding 175 182 1408 1415 O

Fertile 0 7 1416 1423 O
males 8 13 1424 1429 B-gender
who 14 17 1430 1433 O
are 18 21 1434 1437 O
unwilling 22 31 1438 1447 B-contraception_consent
to 32 34 1448 1450 I-contraception_consent
use 35 38 1451 1454 I-contraception_consent
contraceptive 39 52 1455 1468 I-contraception_consent
techniques 53 63 1469 1479 I-contraception_consent
during 64 70 1480 1486 O
and 71 74 1487 1490 O
for 75 78 1491 1494 O
the 79 82 1495 1498 O
twelve 83 89 1499 1505 B-upper_bound
months 90 96 1506 1512 I-upper_bound
following 97 106 1513 1522 O
treatment 107 116 1523 1532 B-treatment

HIV 0 3 1533 1536 B-chronic_disease
seropositive 4 16 1537 1549 O
patients 17 25 1550 1558 O

HIV 0 3 1559 1562 B-chronic_disease
- 3 4 1562 1563 O
positive 4 12 1563 1571 O
donors 13 19 1572 1578 O

High 0 4 1579 1583 O
Risk 5 9 1584 1588 O
Neuroblastoma 10 23 1589 1602 B-cancer
( 24 25 1603 1604 I-cancer
NB 25 27 1604 1606 I-cancer
): 27 29 1606 1608 I-cancer
Must 30 34 1609 1613 O
have 35 39 1614 1618 O
progressed 40 50 1619 1629 O
on 51 53 1630 1632 O
or 54 56 1633 1635 O
recurred 57 65 1636 1644 O
after 66 71 1645 1650 O
standard 72 80 1651 1659 O
frontline 81 90 1660 1669 B-treatment
therapy 91 98 1670 1677 I-treatment
including 99 108 1678 1687 O
autologous 109 119 1688 1698 B-treatment
HCT 120 123 1699 1702 I-treatment
, 123 124 1702 1703 O
or 125 127 1704 1706 O
be 128 130 1707 1709 O
ineligible 131 141 1710 1720 O
for 142 145 1721 1724 O
autologous 146 156 1725 1735 O
HCT 157 160 1736 1739 O

High 0 4 1740 1744 O
- 4 5 1744 1745 O
Risk 5 9 1745 1749 O
Rhabdomyosarcoma 10 26 1750 1766 B-cancer
( 27 28 1767 1768 I-cancer
RMS 28 31 1768 1771 I-cancer
) 31 32 1771 1772 I-cancer
or 33 35 1773 1775 O
Intermediate 36 48 1776 1788 O
Risk 49 53 1789 1793 O
Alveolar 54 62 1794 1802 O
RMS 63 66 1803 1806 O
recurring 67 76 1807 1816 O
as 77 79 1817 1819 O
more 80 84 1820 1824 O
than 85 89 1825 1829 O
loco 90 94 1830 1834 O
- 94 95 1834 1835 O
regional 95 103 1835 1843 O
tumor 104 109 1844 1849 B-cancer
: 109 110 1849 1850 O
Must 111 115 1851 1855 O
have 116 120 1856 1860 O
progressed 121 131 1861 1871 O
on 132 134 1872 1874 O
or 135 137 1875 1877 O
recurred 138 146 1878 1886 O
after 147 152 1887 1892 O
standard 153 161 1893 1901 O
frontline 162 171 1902 1911 O
therapy 172 179 1912 1919 B-treatment
which 180 185 1920 1925 O
includes 186 194 1926 1934 O
chemotherapy 195 207 1935 1947 B-treatment
with 208 212 1948 1952 I-treatment
vincristine 213 224 1953 1964 I-treatment
, 224 225 1964 1965 O
actinomycin 226 237 1966 1977 B-treatment
, 237 238 1977 1978 O
and 239 242 1979 1982 O
cyclophosphamide 243 259 1983 1999 B-treatment
AND 260 263 2000 2003 I-treatment
either 264 270 2004 2010 O
surgery 271 278 2011 2018 B-treatment
or 279 281 2019 2021 O
radiotherapy 282 294 2022 2034 B-treatment

Life 0 4 2035 2039 B-clinical_variable
expectancy 5 15 2040 2050 I-clinical_variable
severely 16 24 2051 2059 O
limited 25 32 2060 2067 O
by 33 35 2068 2070 O
diseases 36 44 2071 2079 O
other 45 50 2080 2085 O
than 51 55 2086 2090 O
malignancy 56 66 2091 2101 B-cancer

Liver 0 5 2102 2107 O
: 5 6 2107 2108 O
Patient 7 14 2109 2116 O
with 15 19 2117 2121 O
clinical 20 28 2122 2130 O
or 29 31 2131 2133 O
laboratory 32 42 2134 2144 O
evidence 43 51 2145 2153 O
of 52 54 2154 2156 O
liver 55 60 2157 2162 B-chronic_disease
disease 61 68 2163 2170 I-chronic_disease
will 69 73 2171 2175 O
be 74 76 2176 2178 O
evaluated 77 86 2179 2188 O
for 87 90 2189 2192 O
the 91 94 2193 2196 O
cause 95 100 2197 2202 O
of 101 103 2203 2205 O
liver 104 109 2206 2211 O
disease 110 117 2212 2219 O
, 117 118 2219 2220 O
its 119 122 2221 2224 O
clinical 123 131 2225 2233 O
severity 132 140 2234 2242 O
in 141 143 2243 2245 O
terms 144 149 2246 2251 O
of 150 152 2252 2254 O
liver 153 158 2255 2260 O
function 159 167 2261 2269 O
, 167 168 2269 2270 O
bridging 169 177 2271 2279 O
fibrosis 178 186 2280 2288 B-chronic_disease
, 186 187 2288 2289 O
and 188 191 2290 2293 O
the 192 195 2294 2297 O
degree 196 202 2298 2304 O
of 203 205 2305 2307 O
portal 206 212 2308 2314 B-chronic_disease
hypertension 213 225 2315 2327 I-chronic_disease

No 0 2 2328 2330 O
age 3 6 2331 2334 B-age
restrictions 7 19 2335 2347 O

Only 0 4 2348 2352 O
subjects 5 13 2353 2361 O
who 14 17 2362 2365 O
are 18 21 2366 2369 O
not 22 25 2370 2373 O
appropriate 26 37 2374 2385 O
candidates 38 48 2386 2396 O
for 49 52 2397 2400 O
autologous 53 63 2401 2411 B-treatment
or 64 66 2412 2414 O
HLA 67 70 2415 2418 B-treatment
- 70 71 2418 2419 I-treatment
matched 71 78 2419 2426 I-treatment
sibling 79 86 2427 2434 I-treatment
hematopoietic 87 100 2435 2448 I-treatment
cell 101 105 2449 2453 I-treatment
transplants 106 117 2454 2465 I-treatment
( 118 119 2466 2467 I-treatment
HCT 119 122 2467 2470 I-treatment
) 122 123 2470 2471 I-treatment
may 124 127 2472 2475 O
be 128 130 2476 2478 O
enrolled 131 139 2479 2487 O

Osteosarcoma 0 12 2488 2500 B-cancer
: 12 13 2500 2501 O
Must 14 18 2502 2506 O
have 19 23 2507 2511 O
progressed 24 34 2512 2522 O
or 35 37 2523 2525 O
recurred 38 46 2526 2534 O
after 47 52 2535 2540 O
standard 53 61 2541 2549 B-treatment
frontline 62 71 2550 2559 I-treatment
therapy 72 79 2560 2567 I-treatment

Patients 0 8 2568 2576 O
who 9 12 2577 2580 O
have 13 17 2581 2585 O
reached 18 25 2586 2593 O
radiation 26 35 2594 2603 B-treatment
threshold 36 45 2604 2613 O
limits 46 52 2614 2620 O
and 53 56 2621 2624 O
are 57 60 2625 2628 O
excluded 61 69 2629 2637 O
from 70 74 2638 2642 O
receiving 75 84 2643 2652 O
3 85 86 2653 2654 O
Gy 87 89 2655 2657 O
TBI 90 93 2658 2661 B-chronic_disease

Patients 0 8 2662 2670 O
who 9 12 2671 2674 O
have 13 17 2675 2679 O
received 18 26 2680 2688 O
a 27 28 2689 2690 O
prior 29 34 2691 2696 B-treatment
allogeneic 35 45 2697 2707 I-treatment
HCT 46 49 2708 2711 I-treatment
are 50 53 2712 2715 O
ineligible 54 64 2716 2726 O

Patients 0 8 2727 2735 O
with 9 13 2736 2740 O
poorly 14 20 2741 2747 O
controlled 21 31 2748 2758 O
hypertension 32 44 2759 2771 B-chronic_disease
despite 45 52 2772 2779 O
multiple 53 61 2780 2788 O
antihypertensive 62 78 2789 2805 B-treatment
medications 79 90 2806 2817 I-treatment

Patients 0 8 2818 2826 O
with 9 13 2827 2831 O
serious 14 21 2832 2839 O
active 22 28 2840 2846 O
infections 29 39 2847 2857 B-chronic_disease

Patients 0 8 2858 2866 O
, 8 9 2866 2867 O
who 10 13 2868 2871 O
in 14 16 2872 2874 O
the 17 20 2875 2878 O
opinion 21 28 2879 2886 O
of 29 31 2887 2889 O
the 32 35 2890 2893 O
investigator 36 48 2894 2906 O
, 48 49 2906 2907 O
may 50 53 2908 2911 O
not 54 57 2912 2915 O
be 58 60 2916 2918 O
able 61 65 2919 2923 O
to 66 68 2924 2926 O
comply 69 75 2927 2933 O
with 76 80 2934 2938 O
the 81 84 2939 2942 O
treatment 85 94 2943 2952 B-treatment
plan 95 99 2953 2957 O
or 100 102 2958 2960 O
safety 103 109 2961 2967 O
monitoring 110 120 2968 2978 O
requirements 121 133 2979 2991 O
of 134 136 2992 2994 O
the 137 140 2995 2998 O
study 141 146 2999 3004 O
Page 147 151 3005 3009 O
16 152 154 3010 3012 O
of 155 157 3013 3015 O
86 158 160 3016 3018 O
Children 161 169 3019 3027 O
's 169 171 3027 3029 O
Hospital 172 180 3030 3038 O
of 181 183 3039 3041 O
Wisconsin 184 193 3042 3051 O
Medical 194 201 3052 3059 O
College 202 209 3060 3067 O
of 210 212 3068 3070 O
Wisconsin 213 222 3071 3080 O

Performance 0 11 3081 3092 O
status 12 18 3093 3099 O
: 18 19 3099 3100 O
Karnofsky 20 29 3101 3110 B-clinical_variable
or 30 32 3111 3113 O
Lansky 33 39 3114 3120 B-clinical_variable
< 40 41 3121 3122 O
60 41 43 3122 3124 B-upper_bound
% 43 44 3124 3125 I-upper_bound

Pulmonary 0 9 3126 3135 O
: 9 10 3135 3136 O
DLCO 11 15 3137 3141 B-clinical_variable
< 16 17 3142 3143 O
40 17 19 3143 3145 B-upper_bound
% 19 20 3145 3146 I-upper_bound
TLC 21 24 3147 3150 B-clinical_variable
< 25 26 3151 3152 O
40 26 28 3152 3154 O
% 28 29 3154 3155 O
, 29 30 3155 3156 O
FEV1 31 35 3157 3161 B-clinical_variable
< 36 37 3162 3163 O
40 37 39 3163 3165 O
% 39 40 3165 3166 O
and/or 41 47 3167 3173 O
receiving 48 57 3174 3183 O
supplementary 58 71 3184 3197 B-treatment
continuous 72 82 3198 3208 I-treatment
oxygen 83 89 3209 3215 I-treatment

Rapidly 0 7 3216 3223 O
- 7 8 3223 3224 O
progressing 8 19 3224 3235 O
disease 20 27 3236 3243 O
prior 28 33 3244 3249 O
to 34 36 3250 3252 O
HCT 37 40 3253 3256 B-treatment
, 40 41 3256 3257 O
defined 42 49 3258 3265 O
as 50 52 3266 3268 O
clinical 53 61 3269 3277 B-treatment
or 62 64 3278 3280 I-treatment
radiographic 65 77 3281 3293 I-treatment
evidence 78 86 3294 3302 O
of 87 89 3303 3305 O
disease 90 97 3306 3313 O
progression 98 109 3314 3325 O
≤ 110 111 3326 3327 O
3 112 113 3328 3329 B-upper_bound
weeks 114 119 3330 3335 I-upper_bound
prior 120 125 3336 3341 I-upper_bound
to 126 128 3342 3344 O
protocol 129 137 3345 3353 O
registration 138 150 3354 3366 O
despite 151 158 3367 3374 O
previous 159 167 3375 3383 O
achievement 168 179 3384 3395 O
of 180 182 3396 3398 O
stable 183 189 3399 3405 O
or 190 192 3406 3408 O
no 193 195 3409 3411 O
disease 196 203 3412 3419 O
( 204 205 3420 3421 O
Appendix 205 213 3421 3429 O
C 214 215 3430 3431 O
& 216 217 3432 3433 O
D 218 219 3434 3435 O
) 219 220 3435 3436 O

Significant 0 11 3437 3448 O
organ 12 17 3449 3454 B-chronic_disease
dysfunction 18 29 3455 3466 I-chronic_disease
that 30 34 3467 3471 O
would 35 40 3472 3477 O
prevent 41 48 3478 3485 O
compliance 49 59 3486 3496 O
with 60 64 3497 3501 O
conditioning 65 77 3502 3514 O
, 77 78 3514 3515 O
GVHD 79 83 3516 3520 B-treatment
prophylaxis 84 95 3521 3532 I-treatment
, 95 96 3532 3533 O
or 97 99 3534 3536 O
would 100 105 3537 3542 O
severely 106 114 3543 3551 O
limit 115 120 3552 3557 O
the 121 124 3558 3561 O
probability 125 136 3562 3573 O
of 137 139 3574 3576 O
survival 140 148 3577 3585 O

